This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Federal Signal (FSS) Buys PWE, Expands Business Footprint
by Zacks Equity Research
Federal Signal's (FSS) buyout of some assets and operations of PWE will enable it to expand its business footprint apart from strengthening its customer base and aftermarket business.
Tetra Tech (TTEK) Announces Its Financial Outlook for FY20
by Zacks Equity Research
Tetra Tech (TTEK) provides its outlook for the third quarter and fiscal 2020.
Graco's HydroShield Waterborne System to Aid in Spraying Tasks
by Zacks Equity Research
Graco's (GGG) HydroShield Waterborne System is developed to help manufacturers in simplifying waterborne material-spraying tasks.
Berry Global (BERY) Gains From RPC Buyout Amid Cost Woes
by Zacks Equity Research
Berry Global (BERY) benefits from its strong portfolio of products, strength across the healthcare, hygiene and grocery end-markets, and the buyout of RPC. However, rising costs remain concerning.
Enersys (ENS) Suffers From Soft End Markets Amid Pandemic
by Zacks Equity Research
Enersys (ENS) is experiencing difficult end-market conditions on account of the coronavirus outbreak-led market downturn. Also, its high debt level is concerning.
Carlisle (CSL) Declines 19.6% YTD: What's Hurting the Stock?
by Zacks Equity Research
Carlisle (CSL) has been suffering from weak end markets on account of the coronavirus outbreak-led uncertainties, high debt level and other issues.
Nordson (NDSN) Buys Fluortek, Strengthens Product Offerings
by Zacks Equity Research
Nordson's (NDSN) buyout of Fluortek will likely enable it to strengthen its product offerings in the medical device market.
Here's Why You Should Avoid Betting on ITT Stock Right Now
by Zacks Equity Research
ITT has been suffering from a soft demand environment amid the coronavirus outbreak, liquidity concerns and other issues.
EnerSys (ENS) Earnings Miss Estimates in Q4, Decline Y/Y
by Zacks Equity Research
EnerSys' (ENS) fiscal fourth-quarter earnings decline year over year on a fall in net sales.
Stocks & ETFs Beneficiaries of Coronavirus Vaccine Ramp-Up
by Sanghamitra Saha
Efforts in formulating a coronavirus vaccine are heating up. These stocks and ETFs look to be the largest beneficiaries.
Parker-Hannifin (PH) Displays Bright Prospects Amid Risks
by Zacks Equity Research
Parker-Hannifin (PH) is likely to benefit from robust backlog level and acquisitions. However, high realignment expenses and the coronavirus outbreak-led market downturn remain concerning.
Honeywell to Increase FFP2 & FFP3 Face Mask Output in Europe
by Zacks Equity Research
Honeywell (HON) to produce 70 million FFP2 and FFP3 face masks at its Newhouse site in Scotland to help contain the coronavirus pandemic.
Berry Global Announces Addition of Meltblown Asset in Berlin
by Zacks Equity Research
Berry Global (BERY) extended its global Meltex meltblown capacity, with the inclusion of an additional asset for the production of high-efficiency filtration media required for face masks.
Rexnord (RXN) Q4 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Rexnord's (RXN) fiscal fourth-quarter earnings improve year over year on the back of sales growth.
MSA Safety's (MSA) Board Okays 2.4% Hike in Dividend Rate
by Zacks Equity Research
MSA Safety (MSA) rewards shareholders with a 2.4% or 1 cent per share hike in its quarterly dividend rate. This underpins the company's solid cash position.
MRC Global (MRC) Displays Bright Prospects Despite Risks
by Zacks Equity Research
MRC Global (MRC) is likely to gain from contract wins and projects along with its focus on cash flow generation and cost reduction. Low customer demand, and weak oil & gas industry remain concerning.
Nordson Displays Bright Prospects Despite Persistent Risks
by Zacks Equity Research
Nordson (NDSN) is poised to gain from strong medical end markets, growth initiatives and buyouts. Weak Advanced Technology Systems segment and high costs remain concerning.
Middleby (MIDD) Q1 Earnings Surpass Estimates, Sales Miss
by Zacks Equity Research
Middleby's (MIDD) Q1 revenues fall year over year on weak performance across its Commercial Foodservice and Residential Kitchen segments.
Flowserve (FLS) Q1 Earnings Miss Estimates, Decline Y/Y
by Zacks Equity Research
Flowserve's (FLS) Q1 earnings fall year over year due to temporary site closures on account of the coronavirus outbreak.
General Electric (GE) Announces Debt-Restructuring Actions
by Zacks Equity Research
General Electric (GE) commences tender offers for notes previously issued by it and its subsidiaries. Also, its GE Capital segment is considering private debt offerings.
AptarGroup's (ATR) Earnings & Sales Top Estimates in Q1
by Zacks Equity Research
AptarGroup (ATR) registers solid core sales growth in the Pharma segment in Q1, partly offset by decline in core sales in other segments on the coronavirus crisis.
Macquarie (MIC) Earnings and Revenues Miss Estimates in Q1
by Zacks Equity Research
Macquarie's (MIC) first-quarter 2020 revenues decrease 14% year over year on account of lackluster performance across its segments.
Cimpress (CMPR) Q3 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Cimpress' (CMPR) third-quarter fiscal 2020 revenues decrease y/y on account of lackluster performance across most of its segments.
John Bean (JBT) Beats on Q1 Earnings, Withdraws '20 View
by Zacks Equity Research
John Bean Technologies (JBT) reported year-over-year improvement in the first-quarter top line in driven by cost control measures and higher revenues.
Terex (TEX) Posts Wider-Than-Expected Loss in Q1, Scraps View
by Zacks Equity Research
Terex's (TEX) Q1 production declines across global facilities due to lower customer demand and local government mandates on account of the coronavirus outbreak.